CBD is metabolized by the same set of liver enzymes as many other drugs metabolized by and can inhibit or enhance the action of these drugs. To be as safe as possible, check with your doctor and pharmacist before taking NatreLeaf CBD. Most of the research conducted regarding safety centers around the use of CBD in seizure disorders in part because CBD has been used to treat certain seizure disorders for several years and this has the largest amount of data collected. In a recently released study on the safety of CBD in children and adults with Lennox-Gastaut or Dravet syndrome (both seizure disorders), it is found CBD to be effective and safe for long-term use.
Another recent study also found that CBD is safe and effective in treatment-resistant epilepsy. An extension of the previous comprehensive survey on the safety of CBD confirms the favorable safety profile of CBD and reports the most common side effects of CBD to use to increase fatigue, diarrhea, change in appetite, change in weight, dry mouth, changed mood, lower blood pressure slightly. Most of these reported side effects are relatively mild. Who should not use CBD? However, some people do not recommend using CBD. This includes pregnant or nursing women and those with Parkinson’s disease. Most of the studies on relative safety have been short-term, but CBD has been safe when taken by mouth at 300 mg daily for up to 6 months.
According to the World Health Organization (WHO), CBD is safe and effective, demonstrating low dependence and potential for abuse. The National Cancer Institute (NCI) recently reported that because cannabinoid receptors, unlike opioid receptors, are not located in the brainstem regions that control breathing, lethal overdoses of cannabis and cannabinoids do not occur. And according to a US government agency researching cancer. Although cannabinoids are considered by some to be addictive drugs, their addiction potential is much lower than that of prescribed agents or other substance abuse.